全文获取类型
收费全文 | 9812篇 |
免费 | 730篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 203篇 |
妇产科学 | 291篇 |
基础医学 | 1124篇 |
口腔科学 | 129篇 |
临床医学 | 1120篇 |
内科学 | 2392篇 |
皮肤病学 | 273篇 |
神经病学 | 918篇 |
特种医学 | 315篇 |
外科学 | 1331篇 |
综合类 | 195篇 |
一般理论 | 2篇 |
预防医学 | 802篇 |
眼科学 | 367篇 |
药学 | 629篇 |
中国医学 | 5篇 |
肿瘤学 | 475篇 |
出版年
2021年 | 148篇 |
2020年 | 73篇 |
2019年 | 161篇 |
2018年 | 172篇 |
2017年 | 98篇 |
2016年 | 121篇 |
2015年 | 125篇 |
2014年 | 240篇 |
2013年 | 330篇 |
2012年 | 422篇 |
2011年 | 463篇 |
2010年 | 290篇 |
2009年 | 223篇 |
2008年 | 341篇 |
2007年 | 496篇 |
2006年 | 388篇 |
2005年 | 397篇 |
2004年 | 376篇 |
2003年 | 352篇 |
2002年 | 339篇 |
2001年 | 318篇 |
2000年 | 336篇 |
1999年 | 273篇 |
1998年 | 129篇 |
1997年 | 117篇 |
1996年 | 105篇 |
1995年 | 103篇 |
1994年 | 103篇 |
1993年 | 85篇 |
1992年 | 177篇 |
1991年 | 165篇 |
1990年 | 233篇 |
1989年 | 192篇 |
1988年 | 201篇 |
1987年 | 176篇 |
1986年 | 197篇 |
1985年 | 168篇 |
1984年 | 111篇 |
1983年 | 115篇 |
1982年 | 80篇 |
1980年 | 80篇 |
1979年 | 145篇 |
1978年 | 96篇 |
1977年 | 90篇 |
1976年 | 88篇 |
1975年 | 74篇 |
1973年 | 76篇 |
1972年 | 82篇 |
1971年 | 72篇 |
1968年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
941.
942.
943.
944.
Robert Applegate MD James Hermiller MD Jerome Williams MD Paul Gordon MD Julie Doostzadeh PhD Sherry Cao MS Xiaolu Su MS Krishnankutty Sudhir MD Alexandra Lansky MD Charles Simonton MD Gregg Stone MD 《Catheterization and cardiovascular interventions》2010,76(5):644-651
Objective: To evaluate whether an everolimus‐eluting stent (EES) with thinner stent struts and polymer results in less periprocedural myonecrosis and adverse outcomes. Background: Higher periprocedural myocardial infarction (MI) rates have been reported with the TAXUS® EXPRESS2 paclitaxel‐eluting stent (PES) compared to the bare metal EXPRESS2® stent due to more frequent side branch compromise, presumably attributable to the thickness of the stent/polymer on the PES. Methods: In the SPIRIT III trial, we identified 113 patients in the XIENCE V® EES group and 63 patients in the TAXUS EXPRESS2 PES group who met the criteria of having a lesion with a jailed side branch (<2 mm diameter, and <50% stenosis). Two‐year clinical outcomes were evaluated. Results: A periprocedural increase in Creatine Kinase‐MB >1× upper normal level occurred in 9.0% of EES compared to 29.7% of PES patients with jailed side branches, P = 0.01. Through 2 years, major adverse cardiac events (MACE; cardiac death, MI, or target lesion revascularization [TLR]) occurred in 6.8% of EES and 19.0% of PES jailed side branch patients (P = 0.03), with numerically lower rates of MI (2.9% vs. 10.3%, P = 0.07) and TLR (3.9% vs. 10.3%, P = 0.17) in the EES group, with comparable rates of cardiac death (1.9% vs. 1.7%, P = 1.00). Conclusions: In this post‐hoc analysis of the SPIRIT III RCT, patients undergoing stenting of target lesions with jailed side branches with the thin strut and polymer XIENCE V EES compared to the thicker strut TAXUS PES had lower rates of MACE through 2 years due to fewer MIs and TLRs. © 2010 Wiley‐Liss, Inc. 相似文献
945.
Paul C. Gordon MD Robert J. Applegate MD James B. Hermiller MD Steven B. Weinsier MD Julie Doostzadeh PhD Sherry Cao MS Krishnankutty Sudhir MD PhD Alexandra J. Lansky MD Gregg W. Stone MD 《Catheterization and cardiovascular interventions》2010,75(2):179-186
Objective : This study evaluates the safety and efficacy of the XIENCE V® 4.0 mm stent for the treatment of de novo native coronary artery lesions. Background : In the SPIRIT III trial, the XIENCE V® everolimus‐eluting stent (EES), compared with the TAXUS EXPRESS2 paclitaxel‐eluting stent (PES) in 2.5–3.75 mm diameter coronary arteries, resulted in reduced angiographic late loss (LL), noninferior rates of target vessel failure (TVF), and fewer major adverse cardiac events (MACE). Methods : The SPIRIT III 4.0 mm registry was a concurrent arm of the SPIRIT III trial consisting of 69 nonrandomized patients with lesions ≤28 mm in length and reference vessel diameter 3.75–4.25 mm treated with a 4.0 mm EES. The primary endpoint was 8‐month in‐segment LL compared with the randomized PES arm. Results : In‐segment LL was 0.17 ± 0.38 mm in the 4.0 mm EES registry compared with 0.28 ± 0.48 mm in the PES arm (P < 0.0001 for noninferiority). The 1‐year rates of ischemia‐driven TVF (cardiac death, myocardial infarction [MI], or target vessel revascularization) and MACE (cardiac death, MI, or target lesion revascularization [TLR]) were numerically, but not statistically, lower in the 4.0 mm EES patients compared with the randomized PES patients (5.9 vs. 11.3%, P = 0.27 and 5.9 vs. 10.3%, P = 0.36, respectively). There was no difference in 8‐month LL or 1‐year TVF or MACE between the 4.0 mm EES and randomized EES patients. Conclusions : In large coronary arteries, the 4.0 mm EES results in low rates of LL at 8 months and adverse clinical events at 1 year. © 2009 Wiley‐Liss, Inc. 相似文献
946.
947.
948.
Tomomi Koizumi Peter J. Fitzgerald Yasuhiro Honda Stephen G. Ellis Kenneth Kent Steven L. Martin Charles L. Brown A.R. Zaki Masud John B. Patterson Joel Greenberg Mark Friedman Takahiro Uchida Gregg W. Stone 《Cardiovascular Revascularization Medicine》2010,11(3):140-148
BackgroundAlthough effective coverage of coronary diffuse in-stent restenosis (ISR) lesions has warranted the use of multiple drug-eluting stents, the vessel response to paclitaxel-eluting stent (PES) overlap is not fully understood.Methods and materialsIn the TAXUS-V ISR, i.e., comparing PES versus brachytherapy for the treatment of bare-metal ISR, angiographic analyses at 9-month follow-up were available in 184 ISR lesions treated with PES.ResultsIn-stent late loss in entire stented segment of multiple PES (n=50) was 0.45±0.48 mm, whereas that of single PES (n=134) was 0.3±0.47 mm, P=.06. No aneurysm was observed at overlapping PES segments at 9 months. Stent thrombosis up to 9 months was observed in one in each group (single PES, 0.7% vs. multiple PES, 1.8%; P=.47). In a subset of 30 patients, volumetric intravascular ultrasound analysis demonstrated that in-stent net volume obstruction was 12.3±12.4 in single PES (n=20) and 14.9±9.8 in multiple PES (n=10), P=.60. The changes of vessel and lumen at the overlapping PES segment were similar to those of the adjacent 5-mm segments (Δminimum lumen area, mm2: ?1.2±1.0, ?1.1±1.1, ?0.8±0.9, P=.48; Δvessel volume, mm3/mm: ?0.2±1.4, 0.1±1.7, 0.3±1.3, P=.37; proximal, overlap, distal segment, respectively). There was no late incomplete stent apposition at overlapping PES segments.ConclusionsNo in vivo evidence of adverse local vessel response at the site of overlapping PES for the treatment of bare-metal ISR has been demonstrated. 相似文献
949.
Paul D Morrison Judith Nottage James M Stone Sagnik Bhattacharyya Nigel Tunstall Rudolf Brenneisen David Holt Daniel Wilson Alex Sumich Philip McGuire Robin M Murray Shitij Kapur Dominic H ffytche 《Neuropsychopharmacology》2011,36(4):827-836
The main ingredient in cannabis, Δ9-tetrahydrocannabinol (THC), can elicit acute psychotic reactions in healthy individuals and precipitate relapse in schizophrenic patients. However, the neural mechanism of this is unknown. We tested the hypothesis that THC psychopathology is related to changes in electroencephalography (EEG) power or inter-regional coherence. In a within-subjects design, participants (n=16) were given intravenous THC (1.25 mg) or placebo under double-blind conditions, during EEG recordings. Using fast-Fourier transform, EEG data were analyzed for power and coherence in the delta (1–3.5 Hz), theta (3.5–7 Hz), alpha (8–13 Hz), beta (14–25 Hz), low-gamma (30–40 Hz), and high-gamma (60–70 Hz) bands during engagement in the n-back test of working memory (WM). Compared with placebo, THC evoked positive and negative psychotic symptoms, as measured by the positive and negative syndrome scale (p<0.001) and slowed WM performance (p<0.05). Under THC, theta power was specifically reduced, (p<0.001) regardless of WM load; however, the reduction showed no relationship with psychotic symptoms or WM impairment. Coherence between bi-frontal electrodes in the theta band was also reduced by THC (p<0.05) and these reductions correlated with the change-in positive psychotic symptoms (rho=0.79, p<0.001). Bi-frontal specificity was suggested by the absence of a relationship between psychotic symptoms and fronto-parietal coherence. The results reveal that the pro-psychotic effects of THC might be related to impaired network dynamics with impaired communication between the right and left frontal lobes. 相似文献
950.